Blood myo-inositol concentrations in preterm and term infants

[1]  W. R. Lucas,et al.  Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks’ Gestational Age: A Randomized Clinical Trial , 2018, JAMA.

[2]  P. Davis,et al.  Surfactant phospholipid composition of gastric aspirate samples differs between male and female very preterm infants , 2017, Pediatric Research.

[3]  中山 優吏佳.  Cincinnati Children’s Hospital Medical Centerでの海外実習を終えて , 2017 .

[4]  Julie Brown,et al.  Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes. , 2016, The Cochrane database of systematic reviews.

[5]  B. Poindexter,et al.  Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants , 2016, Pediatric Research.

[6]  N. Greene,et al.  Inositol, neural tube closure and the prevention of neural tube defects , 2016, Birth defects research.

[7]  R. Ward,et al.  Inositol Analysis by HPLC and Its Stability in Scavenged Sample Conditions , 2015, Medicinal chemistry.

[8]  M. Hallman.  Inositol During Perinatal Transition , 2015 .

[9]  L. Barberini,et al.  Urinary metabolomics (GC-MS) reveals that low and high birth weight infants share elevated inositol concentrations at birth , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[10]  A. Dessì,et al.  Myoinositol: A new marker of intrauterine growth restriction? , 2013, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[11]  B. Poindexter,et al.  Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23–29 wk , 2013, Pediatric Research.

[12]  J. Allsop,et al.  Myo-inositol metabolism in appropriately grown and growth-restricted fetuses: a proton magnetic resonance spectroscopy study. , 2013, European journal of obstetrics, gynecology, and reproductive biology.

[13]  F. Battaglia,et al.  Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes. , 2012, The Journal of clinical endocrinology and metabolism.

[14]  V. Unfer,et al.  Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use , 2012, Expert opinion on drug delivery.

[15]  Katie A. Burren,et al.  Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometry. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[16]  D. Miao,et al.  Sodium/myo‐inositol cotransporter 1 and myo‐inositol are essential for osteogenesis and bone formation , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  N. Bargalló,et al.  Abnormal brain microstructure and metabolism in small‐for‐gestational‐age term fetuses with normal umbilical artery Doppler , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[18]  R. Wilkening,et al.  The tissue and plasma concentration of polyols and sugars in sheep intrauterine growth retardation , 2010, Experimental biology and medicine.

[19]  S. Kalhan.  Nonglucose carbohydrates and infant nutrition and metabolism. , 2009, The Journal of nutrition.

[20]  F. Battaglia,et al.  Inositol and mannose utilization rates in term and late-preterm infants exceed nutritional intakes. , 2009, The Journal of nutrition.

[21]  J. Greer,et al.  Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of phosphatidylinositol levels in neonatal brain. , 2008, Molecular genetics and metabolism.

[22]  F. Battaglia,et al.  Free Sugar and Sugar Alcohol Concentrations in Human Breast Milk , 2006, Journal of pediatric gastroenterology and nutrition.

[23]  S. Chung,et al.  Sodium/myo‐inositol cotransporter‐1 is essential for the development and function of the peripheral nerves , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  F. Battaglia,et al.  Fetal and Maternal Non-glucose Carbohydrates and Polyols Concentrations in Normal Human Pregnancies at Term , 2005, Pediatric Research.

[25]  M. Ivanova,et al.  Developmental expression and function of aldehyde reductase in proximal tubules of the kidney. , 2005, American journal of physiology. Renal physiology.

[26]  E. Jauniaux,et al.  Polyol concentrations in the fluid compartments of the human conceptus during the first trimester of pregnancy: maintenance of redox potential in a low oxygen environment. , 2005, The Journal of clinical endocrinology and metabolism.

[27]  J. Greer,et al.  Loss of Murine Na+/myo-Inositol Cotransporter Leads to Brain myo-Inositol Depletion and Central Apnea* , 2003, The Journal of Biological Chemistry.

[28]  C. Miller,et al.  Relationship between serum inositol concentration and development of retinopathy of prematurity: a prospective study. , 2000, Journal of pediatric ophthalmology and strabismus.

[29]  J. Carver,et al.  Postnatal inositol levels in preterm infants. , 1997, Journal of perinatology : official journal of the California Perinatal Association.

[30]  K. Hoppu,et al.  Inositol supplementation in premature infants with respiratory distress syndrome. , 1992, The New England journal of medicine.

[31]  B. Holub.  The nutritional importance of inositol and the phosphoinositides. , 1992, The New England journal of medicine.

[32]  R. Chiavacci,et al.  Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition. , 1990, The American journal of clinical nutrition.

[33]  K. Hoppu,et al.  Inositol supplementation in respiratory distress syndrome: relationship between serum concentration, renal excretion, and lung effluent phospholipids. , 1987, The Journal of pediatrics.

[34]  M. Hallman,et al.  Myoinositol in Small Preterm Infants: Relationship Between Intake and Serum Concentration , 1986, Journal of pediatric gastroenterology and nutrition.

[35]  J. Quirk,et al.  myo-Inositol Homeostasis in the Human Fetus , 1983, Obstetrics and gynecology.

[36]  K. Longmuir,et al.  Regulation of lamellar body acidic glycerophospholipid biosynthesis in fetal rabbit lung in organ culture. , 1982, Biochimica et biophysica acta.

[37]  J. Okita,et al.  Phosphatidylinositol-specific phospholipase C in fetal membranes and uterine decidua. , 1981, The Journal of clinical investigation.

[38]  O. L. Kline,et al.  Commentary on breast-feeding and infant formulas, including proposed standards for formulas. , 1976, Pediatrics.

[39]  M. Walsh,et al.  Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23–29 wk , 2016, Pediatric Research.

[40]  D. Troyer,et al.  Inositol phospholipid metabolism in the kidney. , 1986, Annual review of physiology.

[41]  B. Holub.  Metabolism and function of myo-inositol and inositol phospholipids. , 1986, Annual review of nutrition.

[42]  R. Porreco,et al.  Role of myoinositol in regulation of surfactant phospholipids in the newborn. , 1985, Early human development.

[43]  S. Melmed,et al.  Myoinositol in Human Neonates: Serum Concentrations and Renal Handling , 1978, Pediatric Research.